Hutch News

Hutch News

Stories tagged 'Jim Kublin'

Enlisting the microbiome in the quest for an AIDS vaccine

We now know that microbial communities, especially in our guts, profoundly affect immune response

Nov. 22, 2017 | By Sabin Russell / Fred Hutch News Service

Scientists at Fred Hutch are studying how the microbiome alters the immune system’s response to vaccines. Their work is already providing new insights on interactions between microbes in the body and the immune system that have implications for improving many types of vaccines.

View story >


On the path to a new-generation malaria vaccine

New approach using genetically modified parasite ‘primes the immune system’ in first human trial

Jan. 4, 2017 | By Mary Engel / Fred Hutch News Service

Volunteers in a clinical trial led by Fred Hutch's Dr. Jim Kublin endured 150 to 200 mosquito bites in one 10-minute session to test a new approach to a malaria vaccine that uses genetically attenuated, or weakened, parasites to stimulate an immune response to malaria without causing disease.

View story >


Nov. 21, 2016

To highlight the breadth new discoveries about the human microbiome, here is a snapshot of just five recent surprising and important findings that may affect your health.

View story >


'Roz and Ray': An HIV tragedy with lessons for today

Seattle Repertory drama, panel explore fallout from an early AIDS crisis in hemophiliacs

Nov. 3, 2016 | By Mary Engel / Fred Hutch News Service

A Seattle Repertory drama and a panel of physician-scientists and activists from Fred Hutch, SCCA and the Bleeding Disorder Foundation of Washington explore the fallout from an early AIDS crisis in hemophiliacs.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Oct. 13, 2016

Dr. David Maloney named cellular immunotherapy medical director at Fred Hutch, SCCA; Dr. Jim Kublin gets grant to study how gut bugs alter HIV vaccine response.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

July 8, 2016

Dr. Colleen Delaney leads first test of "off-the-shelf" cord blood cell product outside the transplant setting; Dr. Justin Taylor receives Hartwell Foundation award to research alternative to RSV vaccine

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.